Search for dissertations about: "Real-Time Cell Binding Assays"
Showing result 1 - 5 of 9 swedish dissertations containing the words Real-Time Cell Binding Assays.
-
1. Novel Methods for Analysis of Heterogeneous Protein-Cell Interactions : Resolving How the Epidermal Growth Factor Binds to Its Receptor
Abstract : Cells are complex biological units with advanced signalling systems, a dynamic capacity to adapt to its environment, and the ability to divide and grow. In fact, they are of such high level of complexity that it has deemed extremely difficult or even impossible to completely understand cells as complete units. READ MORE
-
2. Towards time-resolved molecular interaction assays in living bacteria
Abstract : Rare and neglected diseases such as multidrug resistant (MDR) tuberculosis, malaria and trypanosomiasis are re-emerging in Europe. New strategies are needed to accelerate drug discovery to fight these pathogens. READ MORE
-
3. Deciphering Binding Patterns of Therapeutic Antibodies with Immune Cells : From Method Development to Application
Abstract : Reversible binding, for example between signaling molecules and receptors on the cell surface, is one of the main means to communicate information in cellular systems. Knowledge about how molecules interact is crucial for both understanding biological function and for therapeutic intervention. READ MORE
-
4. The effect of chronic alcoholism on epigenetic patterns regulating gene expression and neurodegeneration in the human brain
Abstract : Chronic alcoholism causes about 3.2% of all deaths worldwide. It has an association to about 60 different diseases and injuries with enormous social and economical impact. Despite these facts, very few pharmacological treatments exist and we can still not explain the mechanisms behind addiction, craving and cognitive impairments seen in the abuser. READ MORE
-
5. Accelerating the discovery of drugs for Neglected Tropical Diseases using biophysical methods
Abstract : Even though they account for 10% of the global disease burden and besides the new record of funding in 2018, tropical diseases are still neglected by the majority of pharmaceutical companies and public funding. The reason can be mostly found in the fact that for these diseases a conventional drug discovery process is often too expensive. READ MORE